ATRS: Antares Pharma, Inc.
2022-03-29 07:00:00
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
2022-03-29 07:00:00
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy